References
- Centers for Disease Control and Prevention: Antibiotic Resistance Threats in the United States, 2019. Atlanta GA: Centers for Disease Control and Prevention; Available at: https://www.cdc.gov/drugresistance/pdf/threatsreport/2019-ar-threats-report-508.pdf.
- Wright AE. Notes on the treatment of furunculosis, sycosis, and acne by the inoculation of a staphylococcus aureus vaccine. Lancet. 1902;159(159):874–884.
- Armentrout EI, Liu GY, Martins GA, et al. Immunity and the quest for protective vaccines against staphylococcus aureus infection. Microorganisms. 2020;8(12):1936.
- Miller LS, Fowler VG, Shukla SK, et al. Development of a vaccine against Staphylococcus aureus invasive infections: evidence based on human immunity, genetics and bacterial evasion mechanisms. FEMS Microbiol Rev. 2020;44(1):123–153.
- Tsai CM, Caldera JR, Hajam IA, et al. Non-protective immune imprint underlies failure of Staphylococcus aureus IsdB vaccine. Cell Host Microbe. 2022;30(8):1163–1172 e1166.
- Tsai CM, Hajam IA, Caldera JR, et al. Integrating complex host-pathogen immune environments into S. aureus vaccine studies. Cell Chem Biol. 2022;29(5):730–740.
- Lebon A, Labout JA, Verbrugh HA, et al. Dynamics and determinants of Staphylococcus aureus carriage in infancy: the generation R study. J Clin Microbiol. 2008;46(10):3517–3521.
- Fowler VG, Allen KB, Moreira ED, et al. Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA. 2013;309(13):1368–1378.
- Francis T. On the doctrine of original antigenic sin. Proc Am Philos Soc. 1960;104(6):572–578.
- Fernandez J, Sanders H, Henn J, et al. Vaccination with detoxified leukocidin AB reduces bacterial load in a staphylococcus aureus minipig deep surgical wound infection model. J Infect Dis. 2022;225(8):1460–1470.
- Fattom A, Matalon A, Buerkert J, et al. Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: phase III randomized study. Hum Vaccin Immunother. 2015;11(3):632–641.
- Forsgren A, Sjoquist J. “Protein A” from S. aureus. I. Pseudo-immune reaction with human gamma-globulin. J Immunol. 1966;97(6):822–827.
- Goodyear CS, Silverman GJ. Death by a B cell superantigen: in vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal Toxin. J Exp Med. 2003;197(9):1125–1139.
- Pauli NT, Kim HK, Falugi F, et al. Staphylococcus aureus infection induces protein A-mediated immune evasion in humans. J Exp Med. 2014;211(12):2331–2339.
- Kim HK, Cheng AG, Kim HY, et al. Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice. J Exp Med. 2010;207(9):1863–1870.
- Teymournejad O, Montgomery CP. Evasion of immunological memory by S. aureus infection: implications for vaccine design. Front Immunol. 2021;12:633672.
- Si Y, Zhao F, Beesetty P, et al. Inhibition of protective immunity against Staphylococcus aureus infection by MHC-restricted immunodominance is overcome by vaccination. Sci Adv. 2020;6(14):eaaw7713.
- Mirzaei B, Babaei R, Valinejad S. Staphylococcal Vaccine Antigens related to biofilm formation. Hum Vaccin Immunother. 2021;17(1):293–303.
- Gjertsson I, Hultgren OH, Stenson M, et al. B lymphocytes of importance in severe Staphylococcus aureus infections? Infect Immun. 2000;68(5):2431–2434.
- Fowler VG Jr., Proctor RA. Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect. 2014;20(Suppl 5):66–75.
- Hidron AI, Kempker R, Moanna A, et al. Staphylococcus aureus in HIV-infected patients. Infect Drug Resist. 2010;3(73–86):73–86.
- Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008;452(7188):773–776.
- Fiege JK, Block KE, Pierson MJ, et al. Mice with diverse microbial exposure histories as a model for preclinical vaccine testing. Cell Host Microbe. 2021;29(12):1815–1827.e6.